Berenberg Bank Issues Positive Forecast for Hikma Pharmaceuticals (LON:HIK) Stock Price

Hikma Pharmaceuticals (LON:HIK) had its price objective increased by analysts at Berenberg Bank from GBX 1,800 to GBX 2,300 in a note issued to investors on Wednesday,Digital Look reports. The brokerage presently has a “buy” rating on the stock. Berenberg Bank’s target price points to a potential upside of 83.71% from the company’s previous close.

Other equities research analysts have also issued research reports about the stock. Peel Hunt restated a “buy” rating and issued a GBX 2,170 price target on shares of Hikma Pharmaceuticals in a report on Friday, November 7th. Deutsche Bank Aktiengesellschaft cut their price objective on shares of Hikma Pharmaceuticals from GBX 2,500 to GBX 2,400 and set a “buy” rating on the stock in a report on Friday, January 9th. JPMorgan Chase & Co. lowered their target price on Hikma Pharmaceuticals from GBX 2,500 to GBX 2,400 and set an “overweight” rating for the company in a report on Friday, November 7th. Finally, Jefferies Financial Group reaffirmed a “buy” rating and set a GBX 2,360 target price on shares of Hikma Pharmaceuticals in a research report on Friday, November 7th. Five equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat, Hikma Pharmaceuticals currently has a consensus rating of “Buy” and a consensus price target of GBX 2,326.

Hikma Pharmaceuticals Stock Up 0.4%

Shares of HIK stock traded up GBX 5 on Wednesday, hitting GBX 1,252. The stock had a trading volume of 5,503,024 shares, compared to its average volume of 6,712,777. Hikma Pharmaceuticals has a one year low of GBX 1,233 and a one year high of GBX 2,184. The business has a 50 day moving average price of GBX 1,543.45 and a 200 day moving average price of GBX 1,632.29. The company has a market cap of £2.77 billion, a PE ratio of 7.50, a P/E/G ratio of 2.38 and a beta of 0.72. The company has a quick ratio of 1.27, a current ratio of 1.82 and a debt-to-equity ratio of 63.59.

Hikma Pharmaceuticals Company Profile

At Hikma we help put better health within reach, every day. By creating high-quality medicines and making them accessible to the people who need them, we help to shape a healthier world that enriches all our communities. We help deliver this by living our culture, delivering our strategy, and acting responsibly. We are a trusted, reliable partner and dependable source of over 800+ (as of Feb 2025) high-quality generic, specialty and branded pharmaceutical products that hospitals, physicians and pharmacists need to treat their patients across North America, MENA and Europe.